WebCompany strengthens management team in anticipation of the potential commercial launch of VP-102, if approved. WEST CHESTER, Pa., July 09, 2024 (GLOBE NEWSWIRE) -- Verrica … Web14 Jul 2024 · Prior to joining Verrica, Kohler served as vice president of corporate development and treasurer and vice president, U.S. branded and specialty pharmaceuticals at Endo International. Kohler also served as a senior professional with a middle market investment banking firm and held various roles at Johnson & Johnson.

Verrica Pharmaceuticals Announces Dosing of the First Patient in

Web12 Nov 2024 · Terry Kohler Chief Financial Officer 484.453.3296 [email protected] William Windham Solebury Trout 646.378.2946 [email protected] Media: Zara Lockshin Solebury Trout 646.378.2960... Web12 Apr 2024 · Terry Kohler Chief Financial Officer [email protected]. Kevin Gardner LifeSci Advisors [email protected]. Chris Calabrese LifeSci Advisors ... Verrica's late-stage product candidate, VP-102, is in development to treat molluscum contagiosum (molluscum), common warts and external genital warts, three of the largest unmet needs … sund most

Verrica Pharmaceuticals Announces Dosing of the First Patient in …

Web12 Apr 2024 · Verrica’s late-stage product candidate, VP-102, is in development to treat molluscum, common warts and external genital warts, three of the largest unmet needs in … Web6 Mar 2024 · Verrica is a dermatology therapeutics company developing medications for skin diseases requiring medical interventions. Verrica’s late-stage product candidate, VP-102,is in development to treat molluscum, common Verrica is also developing VP-103,its second cantharidin-based product candidate, for the treatment of plantar warts. Web9 Jul 2024 · Kohler is a strategic and operational finance leader with over 20 years of commercial business experience, most recently at a global pharmaceutical company with … sund manufacturing newburg nd